Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.


TSXV:TLT - Post by User

Comment by gebremeskelon Dec 31, 2024 3:54pm
162 Views
Post# 36382805

RE:A different take

RE:A different takeYou can take it that way. But to me it is a scandal that the sp ever got down to 18 cents. Given trial results and the IP waiting in the wings it is ridiculous that the sp fell below 30 cents. There is a huge gap between stockholder expectations and current market evaluation. Let's hope that gap closes significantly in 2025

Oilminerdeluxe wrote: Jan 02, the share price was 18 cents. Today it is 26. That is a 44% increase in value. Which most would call a success in a year.

Now, that does not comfort frustrated souls among shareholders. But 44%? Come on, that's good. I know, we want it  to be 444% and even more.  But if good news actually arrive, i think we will have several X Dec 2025. One can at least hope The FDA has decided a date for the Pre-Btd talk. Maybe they will stall us even further, but hopefully not. If they approve BTD in the end and partners arrive, I don't think Roger will be seen in a bad light. Wait with the  keelhauling until BTD and partners are not given. Dr. Libiati needs to do her work too. Anyway, a 44% increase in value is better than most. A slight comnfort.  Fingers crossed, we get what we want in forms of approvals, new studies and enhanced value this upcoming year. With that: Happy New Year to all.




<< Previous
Bullboard Posts
Next >>